Glo-Vision Medicaments Limited - Company Profile

It is a pharma public limited company based in Thane, Maharashtra, India, established in 2003.
2003 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Glo-Vision Medicaments Limited

Glo-Vision Medicaments Limited, a active public limited company, was established on 06 June 2003 in Thane, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2003PLC140778. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.65 M.

It upholds a active non-compliant status. Its leadership includes Dinesh Parasmal Raka (Director), Parasmal Uttamchand Raka (Additional Director), Manoj Parasmal Raka (Additional Director). Past directors included Kanakmal Uttamchand Raka, Yogita Manoj Raka, Ratilal Uttamchand Raka. It holds ₹10.37 Cr open charges and ₹2.50 M settled loans. Its latest AGM occurred on 26 September 2017, with the balance sheet filed on 31 March 2017. It is based at Building No.3, Godown Bo.117, 1St Floor, Arihant Commercial Complex, Purna Villag, E, Bhiwand, Thane, Maharashtra, 421302.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2003PLC140778

  • Registration Number

    140778

  • Incorporation Date

    06 June 2003

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹1.65 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 1.65 M
  • Company Age 22 Year, 8 Months
  • Last Filing with ROC 31 Mar 2017
  • Open Charges ₹ 10.37 Cr
  • Satisfied Charges ₹ 2.50 M
  • Revenue Growth **** -99.69%
  • Profit Growth **** 29.83%
  • Ebitda **** 84.10%
  • Net Worth -0.76%
  • Total Assets -0.16%
Company report

Glo-Vision Medicaments Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Glo-Vision Medicaments Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Glo-Vision Medicaments Limited?
Current Directors
Name Designation Appointment Date Status
Dinesh Parasmal Raka Director 06 Jun 2003 Current
Parasmal Uttamchand Raka Additional Director 06 Jul 2010 Current
Manoj Parasmal Raka Additional Director 31 Mar 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2009 Past
Pramod Abcsdd Director 31 Mar 2014 Past
Pramod Abcsdd Director 06 Jul 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Glo-Vision Medicaments.

Glo-Vision Medicaments Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 99.69% decrease. The company also saw a substantial improvement in profitability, with a 29.83% increase in profit. The company's net worth dipped by a decrease of 0.76%.

Glo-Vision Medicaments revenue growth over time
Glo-Vision Medicaments profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -99.69%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -0.16%
*******
*******
*******
*******
Profit or Loss
*******
 29.83%
*******
*******
*******
*******
Net Worth
*******
 -0.76%
*******
*******
*******
*******
EBITDA
*******
 84.10%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Glo-Vision Medicaments?

In 2017, Glo-Vision Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹103,670,000.00

Satisfied Charges

₹2,500,000.00

Charges Breakdown by Lending Institutions
  • Bank Of Baroda : 9.12 Cr
  • Idbi Bank Limited : 1.25 Cr
Latest Charge Details
Date Lender Amount Status
05 Oct 2012 Bank Of Baroda ₹4.50 Cr Open
09 May 2012 Bank Of Baroda ₹1.17 M Open
27 Jul 2011 Bank Of Baroda ₹4.50 Cr Open
09 Dec 2010 Idbi Bank Limited ₹1.25 Cr Open
15 Jan 2005 The Ajantha Urban Co-Op; Bank Ltd. ₹2.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Glo-Vision Medicaments?

Unlock and access historical data on people associated with Glo-Vision Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Glo-Vision Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glo-Vision Medicaments's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Glo-Vision Medicaments
Recent Activity within the Organization
  • Annual General Meeting

    Glo-Vision Medicaments Limited last Annual general meeting of members was held on 26 Sep 2017 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Glo-Vision Medicaments Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was recorded as a recent event.

  • Charges

    The activity A charge with Bank Of Baroda amounted to Rs. 45.00 M with Charge ID 10380696 was registered on 05 Oct 2012. was completed.

  • Charges

    Progress on A charge with Bank Of Baroda of Rs. 45.00 M registered on 27 Jul 2011 with Charge ID 10305404 was modified on 05 Oct 2012. was documented.

  • Charges

    Progress on A charge with Bank Of Baroda amounted to Rs. 1.17 M with Charge ID 10359219 was registered on 09 May 2012. was documented.

  • Charges

    Progress on A charge with Bank Of Baroda amounted to Rs. 45.00 M with Charge ID 10305404 was registered on 27 Jul 2011. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Glo-Vision Medicaments Limited?

The CIN of Glo-Vision Medicaments Limited is U24230MH2003PLC140778.

Where is Glo-Vision Medicaments Limited headquartered?

Glo-Vision Medicaments Limited is headquartered at Building No.3, Godown Bo.117, 1St Floor, Arihant Commercial Complex, Purna Villag, E, Bhiwand, Thane, Maharashtra, 421302.

When was Glo-Vision Medicaments Limited incorporated?

Glo-Vision Medicaments Limited was incorporated on 06 June 2003.

Who are the current directors of Glo-Vision Medicaments Limited?

The current directors of Glo-Vision Medicaments Limited are

What is the primary industry of Glo-Vision Medicaments Limited?

The primary industry of Glo-Vision Medicaments Limited is Pharma.

Is Glo-Vision Medicaments Limited a listed company?

Glo-Vision Medicaments Limited is unlisted.

What is the capital structure of Glo-Vision Medicaments Limited?

The authorized capital of Glo-Vision Medicaments Limited is ₹3.00 M, and the paid-up capital is ₹1.65 M.

What is the compliance status of Glo-Vision Medicaments Limited?

The compliance status of Glo-Vision Medicaments Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available